Researcher
Katleen De Preter
- Keywords (Ghent University):DNA and RNA sequencing, genomics, bioinformatics, single cell analysis, Computational deconvolution, liquid biopsies, biomarker studies
- Disciplines (Flanders Institute for Biotechnology):Analytical biochemistry, Cell death and senescence, Analysis of next-generation sequence data, General diagnostics
- Disciplines (Ghent University):Genomics, Medical metagenomics, Medical genomics, Medical epigenomics, Cancer diagnosis, Cancer biology, Molecular diagnostics
Affiliations
- De Preter Lab (Research group)
Responsible
From25 Oct 2022 → Today - Department of Biomolecular Medicine (Department)
Member
From1 Oct 2018 → Today - Department of Pediatrics and medical genetics (Department)
Member
From1 Oct 2000 → 30 Sep 2018
Projects
11 - 19 of 19
- Development of a non-invasive test to predict immunotherapy response in lung cancer patientsFrom1 Oct 2020 → TodayFunding: FWO junior postdoctoral fellowship
- Non-invasive prediction of immune-therapy response in lung cancer patients (NIPIT)From1 Oct 2020 → TodayFunding: Nonprofit institution or equivalents
- Non-invasive prediction of immunotherapy response for lung cancer patientsFrom1 Nov 2019 → TodayFunding: BOF - projects
- Special Research Fund Professorship in Translational genomics and bioinformaticsFrom1 Oct 2019 → TodayFunding: BOF - ZAP BOF mandates
- SOX11 controlled SWI/SNF combinatorial assembly and neuroblastoma super-enhancer landscapingFrom1 Oct 2018 → 30 Sep 2019Funding: Foundations, funds and other with scientific goal
- Non invasive drug identification for tumors (NIDIT): a tool for precision oncologyFrom1 Oct 2017 → 30 Sep 2023Funding: Nonprofit institution or equivalents
- Development of a data-mining pipeline for drug target identification from circulating transcriptomes of lung cancer patientsFrom1 Jan 2017 → 15 Feb 2020Funding: BOF - Doctoral projects
- Gene-Environment iNteractions in the pathogenesis of Tobacco smoking-induced Lung diseases (GENT-Lung)From1 Jan 2014 → 31 Oct 2019Funding: BOF - Concerted Research Project from 1994
- Bioinformatics for future precision medicine in cancer treatmentFrom1 Oct 2013 → 30 Sep 2015Funding: Nonprofit institution or equivalents
Publications
1 - 10 of 66
- MYCN and SNRPD3 cooperate to maintain a balance of alternative splicing events that drives neuroblastoma progression(2024)
Authors: Alice Salib, Nisitha Jayatilleke, Janith A. Seneviratne, Chelsea Mayoh, Katleen De Preter, Franki Speleman, Belamy B. Cheung, Daniel R. Carter, Glenn M. Marshall
Pages: 363 - 377 - Evaluation of single-sample network inference methods for precision oncology(2024)
Authors: Joke Deschildre, Boris Vandemoortele, Jens Uwe Loers, Katleen De Preter, Vanessa Vermeirssen
- Human iPSC modeling recapitulates in vivo sympathoadrenal development and reveals an aberrant developmental subpopulation in familial neuroblastoma(2024)
Authors: Stéphane Van Haver, Yujie Fan, Sarah-Lee Bekaert, Celine Everaert, Wouter Van Loocke, Vittorio Zanzani, Joke Deschildre, Ines Fernandez Maestre, Adrianna Amaro, Vanessa Vermeirssen, et al.
- Cell-free DNA as a diagnostic and prognostic biomarker in pediatric rhabdomyosarcoma(2023)
Authors: Nathalie S.M. Lak, Lieke M.J. van Zogchel, Lily Zappeij-Kannegieter, Ahmad Javadi, Ruben Van Paemel, Charlotte Vandeputte, Katleen De Preter, Bram De Wilde, Mathieu Chicard, Yasmine Iddir, et al.
- Performance evaluation of RNA purification kits and blood collection tubes in the Extracellular RNA Quality Control (exRNAQC) study(2023)
Authors: Anneleen Decock, Olivier De Wever, Celine Everaert, Hetty Helsmoortel, An Hendrix, Pieter Mestdagh, Annelien Morlion, Jo Vandesompele, Ruben Van Paemel, Francisco Avila Cobos, et al.
Number of pages: 1 - Performance evaluation of RNA purification kits and blood collection tubes in the Extracellular RNA Quality Control (exRNAQC) study(2023)
Authors: Anneleen Decock, Olivier De Wever, Celine Everaert, Hetty Helsmoortel, An Hendrix, Pieter Mestdagh, Annelien Morlion, Jo Vandesompele, Ruben Van Paemel, Francisco Avila Cobos, et al.
Number of pages: 1 - Mitotic dysregulation at tumor initiation creates a therapeutic vulnerability to combination anti-mitotic and pro-apoptotic agents for MYCN-driven neuroblastoma(2023)
Authors: Lei Zhai, Anushree Balachandran, Rebecca Larkin, Janith A. Seneviratne, Sylvia A. Chung, Amit Lalwani, Shoma Tsubota, Dominik Beck, Kenji Kadomatsu, Anneleen Beckers, et al.
- Dramatic impact of blood collection tube and RNA purification method on extracellular RNA transcriptomes(2023)
Authors: Jasper Anckaert, Francisco Avila Cobos, Anneleen Decock, Philippe Decruyenaere, Jill Deleu, Katleen De Preter, Olivier De Wever, Jilke De Wilde, Bert Dhondt, Thibaut D'huyvetter, et al.
Number of pages: 1 - Circulating immune cell dynamics as outcome predictors for immunotherapy in non-small cell lung cancer(2023)
Authors: Alvaro Marcos Rubio, Celine Everaert, Eufra Van Damme, Katleen De Preter, Karim Vermaelen
- Memory of stochastic single-cell apoptotic signaling promotes chemoresistance in neuroblastoma(2023)
Authors: Jordan F. Hastings, Sharissa L. Latham, Alvin Kamili, Madeleine S. Wheatley, Jeremy Z. R. Han, Marie Wong-Erasmus, Monica Phimmachanh, Max Nobis, Chiara Pantarelli, Antonia L. Cadell, et al.